These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34361105)

  • 1. The Role of the IL-6 Cytokine Family in Epithelial-Mesenchymal Plasticity in Cancer Progression.
    Abaurrea A; Araujo AM; Caffarel MM
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3).
    Sterbova S; Karlsson T; Persson E
    Biochem Biophys Res Commun; 2018 Apr; 498(4):769-774. PubMed ID: 29526757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
    Jones SA; Jenkins BJ
    Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis.
    Browning L; Patel MR; Horvath EB; Tawara K; Jorcyk CL
    Cancer Manag Res; 2018; 10():6685-6693. PubMed ID: 30584363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
    Bryson BL; Junk DJ; Cipriano R; Jackson MW
    Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
    Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
    Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and prostate cancer: the role of interleukin 6 (IL-6).
    Nguyen DP; Li J; Tewari AK
    BJU Int; 2014 Jun; 113(6):986-92. PubMed ID: 24053309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis.
    Mishra AB; Nishank SS
    Med Oncol; 2023 May; 40(7):190. PubMed ID: 37247000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Signaling Pathways Related to Epithelial Mesenchymal Transition in Cancer Metastasis.
    Inan S; Hayran M
    Crit Rev Oncog; 2019; 24(1):47-54. PubMed ID: 31679219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring.
    Bhatia S; Monkman J; Toh AKL; Nagaraj SH; Thompson EW
    Biochem J; 2017 Sep; 474(19):3269-3306. PubMed ID: 28931648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
    Dominguez C; David JM; Palena C
    Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies around epithelial-mesenchymal plasticity in cancer metastasis.
    Williams ED; Gao D; Redfern A; Thompson EW
    Nat Rev Cancer; 2019 Dec; 19(12):716-732. PubMed ID: 31666716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer.
    Caligiuri A; Gitto S; Lori G; Marra F; Parola M; Cannito S; Gentilini A
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance.
    Garg M
    Cancer Metastasis Rev; 2022 Mar; 41(1):131-145. PubMed ID: 34978017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Taniguchi K; Karin M
    Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
    Qu X; Tang Y; Hua S
    Front Immunol; 2018; 9():563. PubMed ID: 29662489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
    BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.